Bicycle Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Bicycle Therapeutics stock have a consensus rating of "Buy" and an average price target of $13.75, which forecasts a 191.31% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $36.

Price Target: $13.75 (+191.31%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.00	$13.75	$12	$36
Change	+48.31%	+191.31%	+154.24%	+662.71%

* Price targets were last updated on Apr 8, 2026.

Analyst Ratings

The average analyst rating for Bicycle Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	1	1	1
Buy	4	4	4	5	5	4
Hold	5	5	5	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	10	10	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold Maintains $13 → $12	Hold	Maintains	$13 → $12	+154.24%	Apr 8, 2026
Jay Olson Oppenheimer	Oppenheimer	Buy Maintains $44 → $36	Buy	Maintains	$44 → $36	+662.71%	Mar 18, 2026
Leonid Timashev RBC Capital	RBC Capital	Hold Maintains $11 → $7	Hold	Maintains	$11 → $7	+48.31%	Mar 18, 2026
Brett Knoblauch Citizens	Citizens	Buy Maintains $12 → $8	Buy	Maintains	$12 → $8	+69.49%	Mar 18, 2026
Ami Fadia Needham	Needham	Strong Buy Maintains $24 → $15	Strong Buy	Maintains	$24 → $15	+217.80%	Mar 18, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

26.43M

from 72.59M

-63.59%

from 72.59M

Revenue Next Year

18.67M

from 26.43M

-29.36%

from 26.43M

EPS This Year

-2.33

from -3.16

EPS Next Year

-2.50

from -2.33

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	11.70M	14.46M	26.98M	35.28M	72.59M	26.43M	18.67M
Revenue Growth	12.58%	23.65%	86.52%	30.76%	105.77%	-63.59%	-29.36%
EPS	-2.67	-3.80	-5.08	-2.90	-3.16	-2.33	-2.50
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	63.0M	75.6M
Avg	26.4M	18.7M
Low	3.1M	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-13.2%	186.1%
Avg	-63.6%	-29.4%
Low	-95.7%	-

EPS Forecast

EPS	2026	2027
High	-1.39	-1.39
Avg	-2.33	-2.50
Low	-2.80	-4.39

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.